期刊文献+

血清肝细胞生长因子与高血压患者合并急性冠脉综合征的相关性 被引量:4

Hepatocyte growth factor in patients with hypertension combined with acute coronary syndrome
下载PDF
导出
摘要 目的 探讨肝细胞生长因子(HGF)在原发性高血压及急性冠脉综合征(ACS)患者血清中的表达水平及其临床意义.方法 采用双抗体夹心酶联免疫荧光吸附法(ELISE)测定25例单纯高血压患者、20例高血压合并不稳定型心绞痛(UA)患者、25例高血压合并急性心肌梗死(AMI)患者、25名健康者的HGF血清浓度.结果 单纯高血压组、高血压合并UA组和高血压合并AMI组血清HGF浓度较正常对照组明显高,差异有统计学意义(P<0.01);高血压合并UA组、高血压合并AMI组血清HGF浓度较单纯高血压组明显高,差异有统计学意义(P<0.05);高血压合并AMI组血清HGF浓度较高血压合并UA组明显高,差异有统计学意义(P<0.05).结论 高浓度的HGF与血管内皮损伤和修复以及不稳定的粥样斑块破裂有关.测定HGF浓度将成为早期诊断高血压及其分级的重要指标和早期筛查不稳定冠状动脉粥样硬化斑块的新手段. Objective To observe the serum level of hepatocyte growth factor (HGF) and its clinical significance in primary hypertension and acute coronary syndrome. Methods The levels of serum HGF was measured in 25 simple hypertensive patients, 20 UA and hypertensive patients, 25 AMI and hypertensive patients and 25 normal subjects by using solid-phase double-antibody sandwich enzyme linked immunosorbent assay (ELISA). Results The serum levels of HGF on admission were significantly increased in simple hypertensive,with UA,with AMI patients compared with normal subjects (P〈0.01). There were significant differences between UA and hyper- tensive patients ,AMI and hypertensive patients and simple hypertensive patients(P〈0.05). A significant differences were obviously between AMI and hypertensive patients and UA and hypertensive patients (P〈0.05). Conclusion High serum concentration of HGF is related to repair endothelial cell injury and rupure of unstable atherosclerotie score. Serum HGF levels may provide a serological mark for the diagnosis and grade of hypertension and a new marker for early unstable coronary atherosclerotie score.
出处 《中国心血管病研究》 CAS 2010年第12期912-914,共3页 Chinese Journal of Cardiovascular Research
关键词 肝细胞生长因子 高血压 冠状动脉粥样硬化 心肌梗死 不稳定性 心绞痛 Hepatoeyte growth factor Hypertension Acute coronary syndrome Myocardial infarction Unstable Angina peetoris
  • 相关文献

参考文献9

二级参考文献17

  • 1陈韵岱.易损斑块的早期识别研究进展[J].中华医学信息导报,2007,22(6):14-15. 被引量:5
  • 2Makino H, Aoki M, Hashiya N, et al .Increase in peripheral blood flow by intravenous administration of prostaglandin E1 in patients with peripheral arterial disease, accompanied by up-regulation of hepatocyte growth factor[J]. Hypertens Res, 2004,27(2):85-91.
  • 3[1]Festa A, D′ Agostino R Jr, Howard G, et al. Chronic subclinical inflammation as part of the insulin resistance syndrome:the Insulin Resistance Atherosclerosis Study (IRAS) [ J ]. Circulation, 2000,102: 42 - 47
  • 4[2]Rader DJ. Inflammatory markers of coronary risk[J].N Engl N Med,2000,343:1179-1182
  • 5[3]Pearson TA, Mensah GA,Alexander RW,et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association [ J ]. Circulation, 2003, 107: 499 -511
  • 6[4]Rubins HB, Robins SWJ, Collins D, et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high - density lipoprotein cholesterol. Veterans Affairs High - Density Lipoprorein Cholesterol Intervention Trial Study Croup[J ]. N Engl J Med, 1999,341:410 - 418
  • 7Zarnegar T.Michalopoulos J: Purification and biological characterization of human hepatopoietin A, a polypeptide growth factor for heopatocytes[].Cancer Research.1989
  • 8Nakamura Y,,Morishita R,Higaki J,et al.Expression of local hepatocyte growthfactor systemin vascular tissues[].Biochemical and Biophysical Research Communications.1995
  • 9Nakano N,Morishita R,Moriguchi A,et al.Negative regulation of local hypatocyte growth factor expression by angiotensin Ⅱ and transforming growth factor in blood vessels: potential role of HGF in cardiovascular disease[].Journal of Hypertension.1998
  • 10Nakamura Y,Morishita R,Nakamura S,et al.A vascular modulator, hypatocyte growth factor, is associated with systolic pressure[].Journal of Hypertension.1996

共引文献110

同被引文献39

  • 1范晓红,王春.颈动脉粥样硬化的发病情况及其影响因素的调查与相关分析[J].中华心血管病杂志,2006,34(2):174-175. 被引量:80
  • 2宁光.糖尿病神经病变的诊断和治疗[J].国际内分泌代谢杂志,2006,26(3). 被引量:107
  • 3王邦宁,胡泽平,陈大年,刘敏,骆志刚,曹海学,解玉泉,宋兵,曹中,程源.高血压患者血肝细胞生长因子与血管内皮功能的关系及干预研究[J].中华高血压杂志,2007,15(3):219-222. 被引量:16
  • 4陈韵岱.易损斑块的早期识别研究进展[J].中华医学信息导报,2007,22(6):14-15. 被引量:5
  • 5Kawamoto R, Oka Y, Yoshida O,et al. Significance of serum circulating hepatocyte growth factor in the development of carotid atherosclerosis [ J ]. J Atheroscler Thromb, 2003,10(3) :154 -159.
  • 6I Suzuki H, Yorozuya M, Makishima N, et al. Changes of ser- um hepatocyte growth factor in coronary artery disease [ J ]. J Cardiol,2000,35(5) : 319 -324.
  • 7Susen S, Sautiere K, Mouquet F, et al. Serum hepatocyte growth factor levels predict long - term clinical outcome af- ter percutaneous coronary revascularization [ J ]. Eur Heart J,2005,26(22) :2387 - 2395.
  • 8Heeschen C, Dimmeler S, Hamm CW, et al. Prognostic sig- nificance of angiogenic growth factor serum levels in patients with acute coronary syndromes [ J ]. Circulation, 2003, 107 (4) 524 -530.
  • 9Tan Bk, Adya R, Farhatullah S, et al. Omentin-1, a novel ad- ipokine, is decreased in overweight insulin-resistant women with polycystie ovary syndrome ex vivo and in vivo regulation of omentin-1 by insulin and glucose. Diabetes, 2008, 57:801- 808.
  • 10Tan BK, Pua S, Syed F, et al. Decreased plasma omentin-1 levels in type 1 diabetes mellitus. Diabet Med:2008, 25: 1254-1255.

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部